About Sharon
Sharon is responsible for drug discovery and early development as well as discovery and development of diagnostics, data sciences, genomics, bioinformatics, clinical biomarkers, and bioanalytical sciences supporting the Alexion pipeline. With more than 18 years of industry experience she has previously led translational research, precision medicines, and global drug development teams at small and large companies.
Sharon received her PhD in molecular biology from New York University, and completed a postdoctoral fellowship on Mechanisms of DNA Damage and Repair at Stanford University.
